The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cannabis-based Medicines Market Research Report 2025
Synopsis
Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
The global Cannabis-based Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cannabis-based Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis-based Medicines.
Report Scope
The Cannabis-based Medicines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabis-based Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis-based Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Segment by Type
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Segment by Application
Oral Solution
Tablets
Patches
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis-based Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
The global Cannabis-based Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cannabis-based Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis-based Medicines.
Report Scope
The Cannabis-based Medicines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabis-based Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis-based Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Segment by Type
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Segment by Application
Oral Solution
Tablets
Patches
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis-based Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CBD (Cannabidiol) Based
1.2.3 THC (Tetrahydrocannabinol) Based
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cannabis-based Medicines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis-based Medicines Market Perspective (2019-2030)
2.2 Cannabis-based Medicines Growth Trends by Region
2.2.1 Global Cannabis-based Medicines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cannabis-based Medicines Historic Market Size by Region (2019-2024)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Region (2025-2030)
2.3 Cannabis-based Medicines Market Dynamics
2.3.1 Cannabis-based Medicines Industry Trends
2.3.2 Cannabis-based Medicines Market Drivers
2.3.3 Cannabis-based Medicines Market Challenges
2.3.4 Cannabis-based Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis-based Medicines Players by Revenue
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2019-2024)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2019-2024)
3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
3.4 Global Cannabis-based Medicines Market Concentration Ratio
3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2023
3.5 Cannabis-based Medicines Key Players Head office and Area Served
3.6 Key Players Cannabis-based Medicines Product Solution and Service
3.7 Date of Enter into Cannabis-based Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis-based Medicines Breakdown Data by Type
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2019-2024)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2025-2030)
5 Cannabis-based Medicines Breakdown Data by Application
5.1 Global Cannabis-based Medicines Historic Market Size by Application (2019-2024)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cannabis-based Medicines Market Size (2019-2030)
6.2 North America Cannabis-based Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cannabis-based Medicines Market Size by Country (2019-2024)
6.4 North America Cannabis-based Medicines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2019-2030)
7.2 Europe Cannabis-based Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cannabis-based Medicines Market Size by Country (2019-2024)
7.4 Europe Cannabis-based Medicines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis-based Medicines Market Size (2019-2030)
8.2 Asia-Pacific Cannabis-based Medicines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cannabis-based Medicines Market Size by Region (2019-2024)
8.4 Asia-Pacific Cannabis-based Medicines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabis-based Medicines Market Size (2019-2030)
9.2 Latin America Cannabis-based Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cannabis-based Medicines Market Size by Country (2019-2024)
9.4 Latin America Cannabis-based Medicines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis-based Medicines Market Size (2019-2030)
10.2 Middle East & Africa Cannabis-based Medicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cannabis-based Medicines Market Size by Country (2019-2024)
10.4 Middle East & Africa Cannabis-based Medicines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Detail
11.1.2 GW Pharmaceuticals plc Business Overview
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2019-2024)
11.1.5 GW Pharmaceuticals plc Recent Development
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Detail
11.2.2 INSYS Therapeutics Business Overview
11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024)
11.2.5 INSYS Therapeutics Recent Development
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Detail
11.3.2 Aequus Pharmaceuticals Business Overview
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.3.5 Aequus Pharmaceuticals Recent Development
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Detail
11.4.2 Axim Biotechnologies Business Overview
11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2019-2024)
11.4.5 Axim Biotechnologies Recent Development
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Detail
11.5.2 Revive Therapeutics Business Overview
11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024)
11.5.5 Revive Therapeutics Recent Development
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Detail
11.6.2 MGC Pharmaceuticals Business Overview
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.6.5 MGC Pharmaceuticals Recent Development
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Detail
11.7.2 ECHO Pharmaceuticals Business Overview
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.7.5 ECHO Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
